Imazapyr Dietary Exposure Assessment DP Barcode: D288806 PC Code: 128821 Page: 1 of 7 UNITED STATES ENVIRONMENTAL PROTECTION AGENCY WASHINGTON, D. C. 20460 OFFICE OF PREVENTION, PESTICIDES AND TOXIC SUBSTANCES MEMORANDUM DATE: 26 MAR 2003 SUBJECT: Imazapyr. Chronic Dietary Exposure Assessment for the Section 3 Registration Action on Grasses and Aquatic Sites.

PC Code: 128821 DP Barcode: D288806 REVIEWER: William H. Donovan, Ph. D., Chemist Reregistration Branch 3 ( RRB3)/ Health Effects Division ( HED) ( 7509C)

THROUGH: Thurston Morton, Chemist Sheila Piper, Chemist Dietary Exposure Science Advisory Council ( DESAC) HED ( 7509C)

and G. Jeffrey Herndon, Branch Senior Scientist Registration Action Branch 1 ( RAB1)/ HED ( 7509C)

TO: Dana Vogel, Risk Assessor RAB1/ HED ( 7509C)

Executive Summary The purpose of this memorandum is to report the results of a dietary exposure analysis for imazapyr. In this analysis the chronic dietary exposure and risk estimates resulting from food intake were determined for the general U. S. population and various population subgroups.

A chronic dietary exposure analysis was performed in order to determine the exposure and risk estimates which result from the addition of fish, shellfish, and livestock commodities to the commodity residue list for imazapyr. The proposed tolerances are associated with Section 3 requests. Imazapyr Dietary Exposure Assessment DP Barcode: D288806 PC Code: 128821 Page: 2 of 7 The chronic dietary analysis for imazapyr shows that the exposure for all population subgroups is below HED's level of concern. All population subgroups are predicted to have exposures < 0.1% of the cPAD.

I. Introduction Dietary risk assessment incorporates both exposure and toxicity of a given pesticide. For acute and chronic assessments, the risk is expressed as a percentage of a maximum acceptable dose. This is the population adjusted dose ( PAD), which HED has concluded will result in no unreasonable adverse health effects. The PAD is the Reference Dose ( RfD) divided by the special FQPA Safety Factor. Dietary risk is expressed as a percentage of the PAD. For acute and noncancer chronic exposures, HED is concerned when estimated dietary risk exceeds 100% of the PAD. References which discuss the acute and chronic risk assessments in more detail are available on the EPA/ pesticides web site: " Available Information on Assessing Exposure from Pesticides, A User's Guide", 6/ 21/ 2000, web link: http:// www. epa. gov/ fedrgstr/ EPA PEST/ 2000/ July/ Day 12/ 6061. pdf ; or see SOP 99.6 ( 8/ 20/ 99).

II. Residue Information New Uses For the proposed new uses, HED recommended tolerance levels were employed in the DEEMFCID analysis together with 100% CT assumptions and DEEM default processing factors. These recommended levels were taken from the appropriate chemistry review ( D275561, W. Donovan, 20 MAR 2003)] and are summarized as follows:

Grass, forage . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100 ppm Grass, hay . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30 ppm Fish . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1.0 ppm Shellfish . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.10 ppm Fat of cattle, sheep, goats, and horses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.05 ppm Kidney of cattle, sheep, goats, and horses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.20 ppm Meat byproducts ( except kidney) of cattle, sheep, goats, and horses . . . . . . . . . . . . . . 0.05 ppm Meat of cattle, sheep, goats, and horses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.05 ppm Milk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.01 ppm Note that the above listed tolerance levels are expressed in terms of imazapyr per se, consistent with the HED Metabolism Assessment Review Committee ( MARC) decision that the residue of concern for the tolerance expression and for risk assessment purposes is parent only in plants, livestock, fish, and water ( TXR# 0051641, W. Donovan and E. Rinde, 13 MAR 2003). Imazapyr Dietary Exposure Assessment DP Barcode: D288806 PC Code: 128821 Page: 3 of 7 Established Uses A listing of established imazapyr tolerances ( for residues of imazapyr per se) is given in 40 CFR § 180.500. This listing consists of field corn raw agricultural commodities ( RACs), all at 0.05 ppm.

III. DEEM FCID   Program and Consumption Information An imazapyr chronic dietary exposure assessment was conducted using the Dietary Exposure Evaluation Model software with the Food Commodity Intake Database ( DEEM FCID   , Version 1.3), which incorporates consumption data from USDA's Continuing Surveys of Food Intakes by Individuals ( CSFII), 1994 1996 and 1998. The 1994 1996 and 1998 data are based on the reported consumption of more than 20,000 individuals over two non consecutive survey days. Foods " as consumed" ( e. g., apple pie) are linked to EPA defined food commodities ( e. g. apples, peeled fruit  cooked; fresh or N/ S; baked; or wheat flour  cooked; fresh or N/ S, baked) using publicly available recipe translation files developed jointly by USDA/ ARS and EPA. Consumption data are averaged for the entire U. S. population and within population subgroups for chronic exposure assessment, but are retained as individual consumption events for acute exposure assessment.

For chronic exposure and risk assessment, an estimate of the residue level in each food or foodform ( e. g., orange or orange juice) on the food commodity residue list is multiplied by the average daily consumption estimate for that food/ food form. The resulting residue consumption estimate for each food/ food form is summed with the residue consumption estimates for all other food/ food forms on the commodity residue list to arrive at the total average estimated exposure. Exposure is expressed in mg/ kg body weight/ day and as a percent of the cPAD. This procedure is performed for each population subgroup.

IV. Toxicological Information The Hazard Identification Assessment Review Committee ( HIARC) discussed the toxicity of imazapyr in a meeting held on 06 FEB 2003 ( TXR# 0051689, E. Rinde, 25 MAR 2003). The relevant dietary exposure toxicological doses and endpoints selected by the HIARC are summarized in Table 1. Based on the HIARC conclusions and the imazapyr risk assessment team's evaluation of the hazard and exposure data, the team recommended that the Special FQPA Safety Factor be reduced to 1x. Imazapyr Dietary Exposure Assessment DP Barcode: D288806 PC Code: 128821 Page: 4 of 7 Table 1. Summary of Toxicological Doses and Endpoints for Imazapyr for Use in Dietary Exposure Assessment Exposure Scenario Dose Used in Risk Assessment, UF FQPA SF* and Endpoint for Risk Assessment Study and Toxicological Effects Acute Dietary females 13 50 years old and general population none none An appropriate endpoint attributable to a single oral dose was not available in the data base.

Chronic Dietary all populations NOAEL= 250 mg/ kg/ day UF = 100 Chronic RfD = 2.5 mg/ kg/ day FQPA SF = 1X cPAD = cRfD FQPA SF = 2.5 mg/ kg/ day 1 year dog ( feeding) study No LOAEL found as 250 mg/ kg/ day was highest dose tested ( HDT). Endpoint of concern may be translated from that of imazapic where skeletal muscle effects were seen in dogs.

Cancer Cancer classification " Group E" in 26 APR 1995 CPRC meeting N/ A N/ A V. Results/ Discussion As stated above, for chronic assessments, HED is concerned when dietary risk exceeds 100% of the cPAD. The DEEM FCID   analysis estimates the dietary exposure of the U. S. population and 26 population subgroups. The results reported in Table 2 are for the general U. S. Population, all infants (< 1 year old), children 1 2, children 3 5, children 6 12, youth 13 19, females 13 49, males 20 49, and adults 50+ years.

Results of Chronic Dietary Exposure Analysis Table 2. Results of Chronic Dietary Exposure Analysis for Imazapyr.

Population Subgroup cPAD ( mg/ kg/ day) Exposure ( mg/ kg/ day) % cPAD General U. S. Population 2.5 0.000340 < 0.1 All Infants (< 1 year old) 2.5 0.000273 < 0.1 Children 1 2 years old 2.5 0.000828 < 0.1 Children 3 5 years old 2.5 0.000730 < 0.1 Children 6 12 years old 2.5 0.000499 < 0.1 Youth 13 19 years old 2.5 0.000309 < 0.1 Imazapyr Dietary Exposure Assessment DP Barcode: D288806 PC Code: 128821 Page: 5 of 7 Table 2. Results of Chronic Dietary Exposure Analysis for Imazapyr.

Population Subgroup cPAD ( mg/ kg/ day) Exposure ( mg/ kg/ day) % cPAD Adults 20 49 years old 2.5 0.000267 < 0.1 Females 13 49 years old 2.5 0.000257 < 0.1 Adults 50+ years old 2.5 0.000287 < 0.1 VI. Discussion of Uncertainties Adequate data are available for the determination of tolerance levels, as discussed in the applicable residue chemistry memos. For fish and shellfish, the tolerance levels are based on residue levels measured in magnitude of the residue studies, as opposed to being based on the method LOQ. For field corn, and all livestock commodities except kidney, the tolerance levels are set at the method LOQ. For kidney, use of maximum grass residue levels in conjunction with the results of a bovine feeding study, allowed projection of a maximum imazapyr residue level of 0.20 ppm ( the recommended tolerance level).

The present dietary exposure analysis made use of tolerance level residues, 100% crop treated assumptions, and DEEM default processing factors. All processing factors in the current analysis were 1.0 except for the " beef, meat, dried" factor where a value of 1.92 was used. Thus, the exposure estimates provided here overestimate the actual risk. With the current low level of risk from imazapyr, refinement was determined to be unnecessary.

VII. Conclusions The Tier 1 chronic dietary risk assessment for imazapyr shows that exposures for all population subgroups are below HED's level of concern. Total food exposure for all population subgroups was determined to occupy < 0.1% cPAD.

VIII. List of Attachments Attachment 1: Imazapyr Tier 1 residue file for chronic DEEM   analysis. Attachment 2: Imazapyr Chronic DEEM   analysis.

cc ( with Attachments): W. Donovan, W. Cutchin RDI: G. Herndon ( 26 MAR 2003) W. H. Donovan: 821B: CM# 2:( 703) 305 7330: 7509C: RRB3 Imazapyr Dietary Exposure Assessment DP Barcode: D288806 PC Code: 128821 Page: 6 of 7 ATTACHMENT 1. RESULTS OF CHRONIC DEEM ANALYSIS.

U. S. Environmental Protection Agency Ver. 1.30 DEEM FCID Chronic analysis for IMAZAPYR ( 1994 98 data) Residue file name: C:\ DEEMFCID\ 128821. r98 Adjustment factor # 2 NOT used. Analysis Date 03 20 2003/ 14: 16: 24 Residue file dated: 03 20 2003/ 14: 11: 01/ 8 Reference dose ( RfD, Chronic) = 2.5 mg/ kg bw/ day COMMENT 1: PP# 0F6166 ( grass & aquatic uses) =============================================================================== Total exposure by population subgroup

Total Exposure  Population mg/ kg Percent of Subgroup body wt/ day Rfd    U. S. Population ( total) 0.000340 0.0%

U. S. Population ( spring season) 0.000360 0.0% U. S. Population ( summer season) 0.000344 0.0% U. S. Population ( autumn season) 0.000334 0.0% U. S. Population ( winter season) 0.000320 0.0%

Northeast region 0.000366 0.0% Midwest region 0.000321 0.0% Southern region 0.000324 0.0% Western region 0.000360 0.0%

Hispanics 0.000349 0.0% Non hispanic whites 0.000312 0.0% Non hispanic blacks 0.000409 0.0% Non hisp/ non white/ non black 0.000566 0.0%

All infants (< 1 year) 0.000273 0.0% Nursing infants 0.000075 0.0% Non nursing infants 0.000348 0.0% Children 1 6 yrs 0.000739 0.0% Children 7 12 yrs 0.000483 0.0%

Females 13 19 ( not preg or nursing) 0.000276 0.0% Females 20+ ( not preg or nursing) 0.000266 0.0% Females 13 50 yrs 0.000273 0.0% Females 13+ ( preg/ not nursing) 0.000244 0.0% Females 13+ ( nursing) 0.000294 0.0%

Males 13 19 yrs 0.000343 0.0% Males 20+ yrs 0.000283 0.0% Seniors 55+ 0.000287 0.0%

Children 1 2 yrs 0.000828 0.0% Children 3 5 yrs 0.000730 0.0% Children 6 12 yrs 0.000499 0.0% Youth 13 19 yrs 0.000309 0.0% Adults 20 49 yrs 0.000267 0.0% Adults 50+ yrs 0.000287 0.0% Females 13 49 yrs 0.000257 0.0%

 Imazapyr Dietary Exposure Assessment DP Barcode: D288806 PC Code: 128821 Page: 7 of 7 ATTACHMENT 2. RESIDUE FILE LISTING FOR IMAZAPYR.

Filename: C:\ DEEMFCID\ 128821. r98 Chemical: Imazapyr RfD( Chronic): 2.5 mg/ kg bw/ day NOEL( Chronic): 250 mg/ kg bw/ day RfD( Acute): 0 mg/ kg bw/ day NOEL( Acute): 0 mg/ kg bw/ day Date created/ last modified: 03 20 2003/ 14: 11: 01/ 8 Program ver. 1.30 Comment: PP# 0F6166 ( grass & aquatic uses)  EPA Crop Def Res Adj. Factors Comment Code Grp Commodity Name ( ppm) # 1 # 2        21000440 M Beef, meat 0.050000 1.000 1.000 N PP# 0F6166 21000441 M Beef, meat babyfood 0.050000 1.000 1.000 N PP# 0F6166 21000450 M Beef, meat, dried 0.050000 1.920 1.000 N PP# 0F6166 21000460 M Beef, meat byproducts 0.050000 1.000 1.000 N PP# 0F6166 21000461 M Beef, meat byproducts babyfood 0.050000 1.000 1.000 N PP# 0F6166 21000470 M Beef, fat 0.050000 1.000 1.000 N PP# 0F6166 21000471 M Beef, fat babyfood 0.050000 1.000 1.000 N PP# 0F6166 21000480 M Beef, kidney 0.200000 1.000 1.000 N PP# 0F6166 21000490 M Beef, liver 0.050000 1.000 1.000 N PP# 0F6166 21000491 M Beef, liver babyfood 0.050000 1.000 1.000 N PP# 0F6166 15001200 15 Corn, field, flour 0.050000 1.000 1.000 PP# 6F4641 15001201 15 Corn, field, flour babyfood 0.050000 1.000 1.000 PP# 6F4641 15001210 15 Corn, field, meal 0.050000 1.000 1.000 PP# 6F4641 15001211 15 Corn, field, meal babyfood 0.050000 1.000 1.000 PP# 6F4641 15001220 15 Corn, field, bran 0.050000 1.000 1.000 PP# 6F4641 15001230 15 Corn, field, starch 0.050000 1.000 1.000 PP# 6F4641 15001231 15 Corn, field, starch babyfood 0.050000 1.000 1.000 PP# 6F4641 15001240 15 Corn, field, syrup 0.050000 1.000 1.000 PP# 6F4641 15001241 15 Corn, field, syrup babyfood 0.050000 1.000 1.000 PP# 6F4641 15001250 15 Corn, field, oil 0.050000 1.000 1.000 PP# 6F4641 15001251 15 Corn, field, oil babyfood 0.050000 1.000 1.000 PP# 6F4641 80001570 F Fish freshwater finfish 1.000000 1.000 1.000 N PP# 0F6166 80001580 F Fish freshwater finfish, farm ra 1.000000 1.000 1.000 N PP# 0F6166 80001590 F Fish saltwater finfish, tuna 1.000000 1.000 1.000 N PP# 0F6166 80001600 F Fish saltwater finfish, other 1.000000 1.000 1.000 N PP# 0F6166 80001610 F Fish shellfish, crustacean 0.100000 1.000 1.000 N PP# 0F6166 80001620 F Fish shellfish, mollusc 0.100000 1.000 1.000 N PP# 0F6166 23001690 M Goat, meat 0.050000 1.000 1.000 N PP# 0F6166 23001700 M Goat, meat byproducts 0.050000 1.000 1.000 N PP# 0F6166 23001710 M Goat, fat 0.050000 1.000 1.000 N PP# 0F6166 23001720 M Goat, kidney 0.200000 1.000 1.000 N PP# 0F6166 23001730 M Goat, liver 0.050000 1.000 1.000 N PP# 0F6166 24001890 M Horse, meat 0.050000 1.000 1.000 N PP# 0F6166 28002210 M Meat, game 0.050000 1.000 1.000 N PP# 0F6166 27002220 D Milk, fat 0.010000 1.000 1.000 N PP# 0F6166 27002221 D Milk, fat  baby food/ infant for 0.010000 1.000 1.000 N PP# 0F6166 27012230 D Milk, nonfat solids 0.010000 1.000 1.000 N PP# 0F6166 27012231 D Milk, nonfat solids baby food/ in 0.010000 1.000 1.000 N PP# 0F6166 27022240 D Milk, water 0.010000 1.000 1.000 N PP# 0F6166 27022241 D Milk, water babyfood/ infant form 0.010000 1.000 1.000 N PP# 0F6166 27032251 D Milk, sugar ( lactose) baby food/ 0.010000 1.000 1.000 N PP# 0F6166 26003390 M Sheep, meat 0.050000 1.000 1.000 N PP# 0F6166 26003391 M Sheep, meat babyfood 0.050000 1.000 1.000 N PP# 0F6166 26003400 M Sheep, meat byproducts 0.050000 1.000 1.000 N PP# 0F6166 26003410 M Sheep, fat 0.050000 1.000 1.000 N PP# 0F6166 26003411 M Sheep, fat babyfood 0.050000 1.000 1.000 N PP# 0F6166 26003420 M Sheep, kidney 0.200000 1.000 1.000 N PP# 0F6166 26003430 M Sheep, liver 0.050000 1.000 1.000 N PP# 0F6166


[Federal Register Volume 88, Number 115 (Thursday, June 15, 2023)]
[Notices]
[Pages 39266-39267]
[FR Doc No: 2023-12810]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Federal Emergency Management Agency

[Docket ID FEMA-2008-0010]

Board of Visitors for the National Fire Academy

AGENCY: Federal Emergency Management Agency, Department of Homeland
Security.

ACTION: Notice of Federal advisory committee meeting.

-----------------------------------------------------------------------

SUMMARY: The Board of Visitors for the National Fire Academy (Board)
will meet in person at the National Emergency Training Center in
Emmitsburg, MD, and virtually on Monday, August 7, 2023. The meeting
will be open to the public.

DATES: The meeting will take place on Monday, August 7, 2023, 8 a.m. to
4 p.m. Eastern Time. Please note that the meeting may close early if
the Board has completed its business.

ADDRESSES: Members of the public who wish to participate in the virtual
conference should contact Deborah Gartrell-Kemp as listed in the FOR
FURTHER INFORMATION CONTACT section by close of business on August 1,
2023, to obtain the call-in number and access code for the August 7th
in-person and virtual meeting. For more information on services for
individuals with disabilities or to request special assistance, contact
Deborah Gartrell-Kemp as soon as possible. The Board is committed to
ensuring all participants have equal access regardless of disability
status. If you require a reasonable accommodation due to a disability
to fully participate, please contact Deborah Gartrell-Kemp as listed in
the FOR FURTHER INFORMATION CONTACT section as soon as possible.
    To facilitate public participation, we are inviting public comment
on the issues to be considered by the Board as listed in the
SUPPLEMENTARY INFORMATION section. Participants seeking to have their
comments considered during the meeting should submit them in advance or
during the public comment segment. Comments submitted up to 30 days
after the meeting will be included in the public record and may be
considered at the next meeting. Comments submitted in advance must be
identified by Docket ID FEMA-2008-0010 and may be submitted by one of
the following methods:
     Federal eRulemaking Portal: http://www.regulations.gov.
Follow the instructions for submitting comments.
     Electronic Delivery: Email Deborah Gartrell-Kemp at
[email protected] no later than August 1, 2023, for
consideration at the August 7, 2023 meeting.
    Instructions: All submissions received must include the words
``Federal Emergency Management Agency'' and the Docket ID for this
action. Comments received will be posted without alteration at http://www.regulations.gov, including any personal information provided. You
may wish to view the Privacy and Security Notice via a link on the
homepage of https://www.regulations.gov.
    Docket: For access to the docket and to read background documents
or comments received by the National Fire Academy Board of Visitors, go
to http://www.regulations.gov, click on ``Advanced Search,'' then enter
``FEMA-2008-0010'' in the ``By Docket ID'' box, then select ``FEMA''
under ``By Agency,'' and then click ``Search.''

FOR FURTHER INFORMATION CONTACT:
    Designated Federal Officer: Eriks Gabliks, telephone (301) 447-
1308, email [email protected].
    Logistical Information: Deborah Gartrell-Kemp, telephone (301) 447-
7230, email [email protected].

SUPPLEMENTARY INFORMATION: The Board will meet in person and virtually
on Monday, August 7, 2023. The meeting will be open to the public.
Notice of this meeting is given under the Federal Advisory Committee
Act, 5 U.S.C. chapter 10.

Purpose of the Board

    The purpose of the Board is to review annually the programs of the
National Fire Academy (Academy) and advise the Administrator of the
Federal Emergency Management Agency (FEMA), through the United States
Fire Administrator, on the operation of the Academy and any
improvements therein that the Board deems appropriate. In carrying out
its responsibilities, the Board examines Academy programs to determine
whether these programs further the basic missions that are approved by
the Administrator of FEMA, examines the physical plant of the Academy
to determine the adequacy of the Academy's facilities, and examines the
funding levels for Academy programs. The Board submits a written annual
report through the United States Fire Administrator to the
Administrator of FEMA. The report provides detailed comments and
recommendations regarding the operation of the Academy.

Agenda

    On Monday, August 7, 2023, there will be four sessions, with
deliberations and voting at the end of each session as necessary:
    1. The Board will discuss United States Fire Administration Data,
EMS, Research, Prevention and Response.
    2. The Board will discuss deferred maintenance and capital
improvements on the National Emergency Training Center campus and
fiscal year 2024 and beyond Budget Request/Budget Planning.
    3. The Board will deliberate and vote on recommendations on Academy
program activities to include developments, deliveries, staffing,
admissions, and strategic plan.
    4. There will also be an update on the Board of Visitors
Subcommittee Groups for the Professional Development Initiative Update
and the National Fire Incident Report System.
    There will be a 10-minute public comment period after each agenda
item and each speaker will be given no more than 2 minutes to speak.
Please note that the public comment period may end before the time
indicated following the last call for comments. Contact Deborah
Gartrell-Kemp to register as a

speaker. Meeting materials will be posted by August 1, 2023, at https://www.usfa.fema.gov/nfa/about/board-of-visitors.html.

Eriks J. Gabliks,
Superintendent, National Fire Academy, United States Fire
Administration, Federal Emergency Management Agency.
[FR Doc. 2023-12810 Filed 6-14-23; 8:45 am]
BILLING CODE 9111-74-P


[Federal Register Volume 81, Number 107 (Friday, June 3, 2016)]
[Notices]
[Pages 35761-35762]
[FR Doc No: 2016-13150]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[ER-FRL-9027-4]

Environmental Impact Statements; Notice of Availability

    Responsible Agency: Office of Federal Activities, General
Information<PHONE_NUMBER> or http://www.epa.gov/nepa.
Weekly receipt of Environmental Impact Statements (EISs)
Filed 05/23/2016 Through 05/27/2016
Pursuant to 40 CFR 1506.9.

Notice

    Section 309(a) of the Clean Air Act requires that EPA make public
its comments on EISs issued by other Federal agencies. EPA's comment
letters on EISs are available at: http://www.epa.gov/compliance/nepa/eisdata.html.
EIS No. 20160112, Draft, USFS, MT, Galton Vegetation Management,
Comment Period Ends: 07/25/2016, Contact: Ron Komac<PHONE_NUMBER> x7130.
EIS No. 20160113, Draft, USFS, MT, Flathead National Forest Plan
Revision and Northern Continental Divide Ecosystem Grizzly Bear
Conservation Strategy Forest Plan Amendments to the Lolo, Helena, Lewis
& Clark, and Kootenai National Forests, Comment Period Ends: 10/03/
2016, Contact: Joe Krueger<PHONE_NUMBER>.
EIS No. 20160114, Final, FHWA, TX, Grand Parkway (State Highway 99)
Segment B, Review Period Ends: 07/05/2016, Contact: Carlos Swonke 512-
416-2734.

EIS No. 20160115, Draft, DOD, Other, Continental United States (CONUS)
Interceptor Site, Comment Period Ends: 07/18/2016, Contact: Christopher
Johnson<PHONE_NUMBER>.
EIS No. 20160116, Final, USACE, FL, Herbert Hoover Dike Dam Safety
Modification Study, Review Period Ends: 07/05/2016, Contact: Stacie
Auvenshine<PHONE_NUMBER>.
EIS No. 20160117, Draft, BR, USACE, MT, Lower Yellowstone Intake
Diversion Dam Fish Passage Project, Comment Period Ends: 07/18/2016,
Contact: Tiffany Vanosdall<PHONE_NUMBER>.
    The U.S. Army Corps of Engineers and the U.S. Department of the
Interior's Bureau of Reclamation are joint lead agencies for this
project.
EIS No. 20160118, Draft, BLM, CO, Uncompahgre Draft Resource Management
Plan, Comment Period Ends: 09/01/2016, Contact: Gina Jones 970-240-
5381.
EIS No. 20160119, Draft, USFS, OR, Green Mountain Project, Comment
Period Ends: 07/18/2016, Contact: Elysia Retzlaff<PHONE_NUMBER>.
EIS No. 20160120, Final, USFWS, CA, South Bay Salt Pond Restoration
Project Phase 2, Review Period Ends: 07/05/2016, Contact: Chris Barr
510-792-0222.
EIS No. 20160121, Draft, USACE, AZ, Little Colorado River, Winslow,
Arizona, Flood Risk Management Project, Comment Period Ends: 07/18/
2016, Contact: Kirk Brus<PHONE_NUMBER>.
EIS No. 20160122, Draft, USFS, AK, Wrangell Island Project, Comment
Period Ends: 07/18/2016, Contact: Andrea Slusser<PHONE_NUMBER>.
EIS No. 20160123, Final, USFS, CO, Spruce Beetle Epidemic and Aspen
Decline Management Response, Review Period Ends: 07/05/2016, Contact:
Samantha Staley<PHONE_NUMBER>.

    Dated: May 31, 2016.
Dawn Roberts,
Management Analyst, NEPA Compliance Division, Office of Federal
Activities.
[FR Doc. 2016-13150 Filed 6-2-16; 8:45 am]
 BILLING CODE 6560-50-P


[Federal Register Volume 81, Number 157 (Monday, August 15, 2016)]
[Notices]
[Pages 54099-54100]
[FR Doc No: 2016-19338]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2016-N-0001]

Allergenic Products Advisory Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) announces a forthcoming
public advisory committee meeting of the Allergenic Products Advisory
Committee. The general function of the committee is to provide advice
and recommendations to the Agency on FDA's regulatory issues. At least
one portion of the meeting will be closed to the public.

DATES: The meeting will be held on October 27, 2016, from 1 p.m. to
4:20 p.m.

ADDRESSES: FDA White Oak Campus, 10903 New Hampshire Ave., Building 31
Conference Center, the Great Room (Rm. 1503), Silver Spring, MD 20993-
0002. Answers to commonly asked questions including information
regarding special accommodations due to a disability, visitor parking,
and transportation may be accessed at: http://www.fda.gov/AdvisoryCommittees/AboutAdvisoryCommittees/ucm408555.htm.

FOR FURTHER INFORMATION CONTACT: Janie Kim or Denise Royster, Center
for Biologics Evaluation and Research, Food and Drug Administration,
10903 New Hampshire Ave., Bldg. 71, Silver Spring, MD 20993-0002, 301-
796-9016 or<PHONE_NUMBER>, email<EMAIL_ADDRESS>or
<EMAIL_ADDRESS>or FDA Advisory Committee Information Line,
1-800-741-8138<PHONE_NUMBER> in the Washington, DC area). A notice in
the Federal Register about last minute modifications that impact a
previously announced advisory committee meeting cannot always be
published quickly enough to provide timely notice. Therefore, you
should always check the Agency's Web site at http://www.fda.gov/AdvisoryCommittees/default.htm and scroll down to the

appropriate advisory committee meeting link, or call the advisory
committee information line to learn about possible modifications before
coming to the meeting. For those unable to attend in person, the
meeting will also be available via Web cast. The Web cast will be
available at the following link: https://collaboration.fda.gov/apac1016/.

SUPPLEMENTARY INFORMATION: Agenda: On October 27, 2016, the committee
will meet by teleconference. In open session, the committee will hear
updates of research programs in the Laboratory of Immunobiochemistry of
the Division of Bacterial, Parasitic and Allergenic Products (DBPAP),
Office of Vaccines Research and Review, Center for Biologics Evaluation
and Research, FDA.
    FDA intends to make background material available to the public no
later than 2 business days before the meeting. If FDA is unable to post
the background material on its Web site prior to the meeting, the
background material will be made publicly available at the location of
the advisory committee meeting, and the background material will be
posted on FDA's Web site after the meeting. Background material is
available at http://www.fda.gov/AdvisoryCommittees/Calendar/default.htm. Scroll down to the appropriate advisory committee meeting
link.
    Procedure: On October 27, 2016, from 1 p.m. to 3:30 p.m., the
meeting is open to the public. Interested persons may present data,
information, or views, orally or in writing, on issues pending before
the committee. Written submissions may be made to the contact person on
or before October 13, 2016. Oral presentations from the public will be
scheduled between approximately 2:30 p.m. and 3:30 p.m. Those
individuals interested in making formal oral presentations should
notify the contact person and submit a brief statement of the general
nature of the evidence or arguments they wish to present, the names and
addresses of proposed participants, and an indication of the
approximate time requested to make their presentation on or before
October 4, 2016. Time allotted for each presentation may be limited. If
the number of registrants requesting to speak is greater than can be
reasonably accommodated during the scheduled open public hearing
session, FDA may conduct a lottery to determine the speakers for the
scheduled open public hearing session. The contact person will notify
interested persons regarding their request to speak by October 5, 2016.
    Closed Committee Deliberations: On October 27, 2016, the meeting
will be closed from 3:35 p.m. to 4:20 p.m. to permit discussion where
disclosure would constitute a clearly unwarranted invasion of personal
privacy (5 U.S.C. 552b(c)(6)). The committee will discuss reports of
intramural research programs and make recommendations regarding
personnel staffing decisions.
    Persons attending FDA's advisory committee meetings are advised
that the Agency is not responsible for providing access to electrical
outlets.
    FDA welcomes the attendance of the public at its advisory committee
meetings and will make every effort to accommodate persons with
disabilities. If you require accommodations due to a disability, please
contact Janie Kim at least 7 days in advance of the meeting.
    FDA is committed to the orderly conduct of its advisory committee
meetings. Please visit our Web site at http://www.fda.gov/AdvisoryCommittees/AboutAdvisoryCommittees/ucm111462.htm for procedures
on public conduct during advisory committee meetings.
    Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).

    Dated: August 9, 2016.
Janice M. Soreth,
Acting Associate Commissioner, Special Medical Programs.
[FR Doc. 2016-19338 Filed 8-12-16; 8:45 am]
 BILLING CODE 4164-01-P


[Federal Register Volume 79, Number 131 (Wednesday, July 9, 2014)]
[Proposed Rules]
[Pages 38797-38799]
[FR Doc No: 2014-16004]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Part 39

[Docket No. FAA-2014-0430; Directorate Identifier 2014-NM-083-AD]
RIN 2120-AA64

Airworthiness Directives; The Boeing Company Airplanes

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Notice of proposed rulemaking (NPRM).

-----------------------------------------------------------------------

SUMMARY: We propose to adopt a new airworthiness directive (AD) for all
The Boeing Company Model 767 airplanes. This proposed AD was prompted
by a report of a rotary actuator for the trailing edge (TE) flap that
had slipped relative to its mating reaction ring, which is attached to
the flap support rib. This proposed AD would require repetitive
inspections for corrosion of the fixed ring gear and reaction ring
splines of the rotary actuator assembly for each support position, and
related investigative and corrective actions if necessary. We are
proposing this AD to detect and correct reaction ring gears and rotary
actuator gears from becoming disengaged with flaps extended and causing
an uncommanded roll due to flap blowback, overload, or flap departure
from the airplane, which could compromise safe flight and landing of
the airplane.

DATES: We must receive comments on this proposed AD by August 25, 2014.

ADDRESSES: You may send comments, using the procedures found in 14 CFR
11.43 and 11.45, by any of the following methods:
     Federal eRulemaking Portal: Go to http://www.regulations.gov. Follow the instructions for submitting comments.
     Fax:<PHONE_NUMBER>.
     Mail: U.S. Department of Transportation, Docket
Operations, M-30, West Building Ground Floor, Room W12-140, 1200 New
Jersey Avenue SE., Washington, DC 20590.
     Hand Delivery: Deliver to Mail address above between 9
a.m. and 5 p.m., Monday through Friday, except Federal holidays.
    For service information identified in this proposed AD, contact
Boeing Commercial Airplanes, Attention: Data & Services Management,
P.O. Box 3707, MC 2H-65, Seattle, WA 98124-2207; telephone 206-544-
5000, extension 1; fax<PHONE_NUMBER>; Internet https://www.myboeingfleet.com. You may view this referenced service information
at the FAA, Transport Airplane Directorate, 1601 Lind Avenue SW.,
Renton, WA. For information on the availability of this material at the
FAA, call<PHONE_NUMBER>.

Examining the AD Docket

    You may examine the AD docket on the Internet at http://www.regulations.gov by searching for and locating Docket No. FAA-2014-
0430; or in person at the Docket Management Facility between 9 a.m. and
5 p.m., Monday through Friday, except Federal holidays. The AD docket
contains this proposed AD, the regulatory evaluation, any comments
received, and other information. The street address for the Docket
Office (phone:<PHONE_NUMBER>) is in the ADDRESSES section. Comments will
be available in the AD docket shortly after receipt.

FOR FURTHER INFORMATION CONTACT: Allen Rauschendorfer, Aerospace
Engineer, Airframe Branch, ANM-120S, FAA, Seattle Aircraft
Certification Office, 1601 Lind Avenue SW., Renton, WA 98057-3356;
phone:<PHONE_NUMBER>; fax:<PHONE_NUMBER>; email:
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

Comments Invited

    We invite you to send any written relevant data, views, or
arguments about this proposal. Send your comments to an address listed
under the ADDRESSES section. Include ``Docket No. FAA-2014-0430;
Directorate Identifier 2014-NM-083-AD'' at the beginning of your
comments. We specifically invite comments on the overall regulatory,
economic, environmental, and energy aspects of this proposed AD. We
will consider all comments received by the closing date and may amend
this proposed AD because of those comments.
    We will post all comments we receive, without change, to http://www.regulations.gov, including any personal information you provide. We
will also post a report summarizing each substantive verbal contact we
receive about this proposed AD.

Discussion

    We have received a report of a TE flap rotary actuator that had
slipped relative to its mating reaction ring, which is attached to the
flap support rib. This occurred on a Model 767-300ER airplane that was
delivered in June 1997 and had accumulated approximately 79,000 total
flight hours and 14,000 total flight cycles in service. Removal of the
reaction ring and actuator revealed that the mating splines were
severely corroded. The manufacturer determined that, if the corrosion
were to affect the mating splines on either surface (actuator or ring)
to the point where they could no longer effectively engage, the
actuator would be prone to possible slippage. Due to the similarity of
the design, the potential condition could develop at multiple flap
supports. Should degradation reach the point where both actuators on a
single flap were unable to react to the torsion created by air loads,
an uncommanded flap retraction, or blowback could occur. The condition
of uncommanded roll with flaps extended, due to flap blowback,
overload, or flap departure from the airplane, could compromise safe
flight and landing of the airplane.

Relevant Service Information

    We reviewed Boeing Alert Service Bulletin 767-27A0229, dated March
4, 2014. For information on the procedures and compliance times, see
this service information at http://www.regulations.gov by searching for
Docket No. FAA-2014-0430.

FAA's Determination

    We are proposing this AD because we evaluated all the relevant
information and determined the unsafe condition described previously is
likely to exist or develop in other products of the same type design.

Proposed AD Requirements

    This proposed AD would require accomplishing the repetitive
inspections for corrosion of the fixed ring gear and reaction ring
splines of the rotary actuator assembly for each support position, and
related investigative and corrective actions if necessary, specified in
the service information described previously.
    The phrase ``related investigative actions'' is used in this
proposed AD. ``Related investigative actions'' are follow-on actions
that (1) are related to the primary actions, and (2) further
investigate the nature of any condition found. Related investigative
actions in an AD could include, for example, inspections.
    The phrase ``corrective actions'' is used in this proposed AD.
``Corrective actions'' are actions that correct or address any
condition found. Corrective actions in an AD could include, for
example, repairs.

Explanation of ``RC'' Steps in Service Information

    The FAA worked in conjunction with industry, under the
Airworthiness Directive Implementation Aviation Rulemaking Committee,
to enhance the

AD system. One enhancement was a new process for annotating which steps
in the service information are required for compliance (RC) with an AD.
Differentiating these steps from other tasks in the service information
is expected to improve an owner's/operator's understanding of crucial
AD requirements and help provide consistent judgment in AD compliance.
The actions specified in the service information described previously
include steps that are labeled as RC (required for compliance) because
these steps have a direct effect on detecting, preventing, resolving,
or eliminating an identified unsafe condition.
    As noted in the specified service information, steps labeled as RC
must be done to comply with the proposed AD. However, steps that are
not labeled as RC are recommended. Those steps that are not labeled as
RC may be deviated from, done as part of other actions, or done using
accepted methods different from those identified in the service
information without obtaining approval of an alternative method of
compliance (AMOC), provided the steps labeled as RC can be done and the
airplane can be put back in a serviceable condition. Any substitutions
or changes to steps labeled as RC will require approval of an AMOC.

Costs of Compliance

    We estimate that this proposed AD affects 389 airplanes of U.S.
registry.
    We estimate the following costs to comply with this proposed AD:

                                                 Estimated Costs
----------------------------------------------------------------------------------------------------------------
                                                                                Cost on U.S.
            Action                  Labor cost          Parts cost      Cost per product          operators
----------------------------------------------------------------------------------------------------------------
Inspection...................  60 work-hours x $85               $0   $5,100 per            $1,983,900 per
                                per hour = $5,100                      inspection cycle..    inspection cycle.
                                per inspection
                                cycle.
----------------------------------------------------------------------------------------------------------------

    We estimate the following costs to do any necessary repairs that
would be required based on the results of the proposed inspection. We
have no way of determining the number of aircraft that might need these
repairs:

                                               On-Condition Costs
----------------------------------------------------------------------------------------------------------------
              Action                        Labor cost             Parts cost            Cost per product
----------------------------------------------------------------------------------------------------------------
Actuator repair...................  4 work-hours x $85 per                  $0   $340 per actuator.
                                     hour = $340 per actuator.
----------------------------------------------------------------------------------------------------------------

Authority for This Rulemaking

    Title 49 of the United States Code specifies the FAA's authority to
issue rules on aviation safety. Subtitle I, section 106, describes the
authority of the FAA Administrator. Subtitle VII: Aviation Programs,
describes in more detail the scope of the Agency's authority.
    We are issuing this rulemaking under the authority described in
Subtitle VII, Part A, Subpart III, Section 44701: ``General
requirements.'' Under that section, Congress charges the FAA with
promoting safe flight of civil aircraft in air commerce by prescribing
regulations for practices, methods, and procedures the Administrator
finds necessary for safety in air commerce. This regulation is within
the scope of that authority because it addresses an unsafe condition
that is likely to exist or develop on products identified in this
rulemaking action.

Regulatory Findings

    We determined that this proposed AD would not have federalism
implications under Executive Order 13132. This proposed AD would not
have a substantial direct effect on the States, on the relationship
between the national Government and the States, or on the distribution
of power and responsibilities among the various levels of government.
    For the reasons discussed above, I certify this proposed
regulation:
    (1) Is not a ``significant regulatory action'' under Executive
Order 12866,
    (2) Is not a ``significant rule'' under the DOT Regulatory Policies
and Procedures (44 FR 11034, February 26, 1979),
    (3) Will not affect intrastate aviation in Alaska, and
    (4) Will not have a significant economic impact, positive or
negative, on a substantial number of small entities under the criteria
of the Regulatory Flexibility Act.

List of Subjects in 14 CFR Part 39

    Air transportation, Aircraft, Aviation safety, Incorporation by
reference, Safety.

The Proposed Amendment

    Accordingly, under the authority delegated to me by the
Administrator, the FAA proposes to amend 14 CFR part 39 as follows:

PART 39--AIRWORTHINESS DIRECTIVES

0
1. The authority citation for part 39 continues to read as follows:

    Authority:  49 U.S.C. 106(g), 40113, 44701.

Sec.  39.13  [Amended]

0
2. The FAA amends Sec.  39.13 by adding the following new airworthiness
directive (AD):

The Boeing Company: Docket No. FAA-2014-0430; Directorate Identifier
2014-NM-083-AD.

(a) Comments Due Date

    We must receive comments by August 25, 2014.

(b) Affected ADs

    None.

(c) Applicability

    This AD applies to all The Boeing Company Model 767-200, -300, -
300F, and -400ER series airplanes, certificated in any category.

(d) Subject

    Air Transport Association (ATA) of America Code 57, Wings.

(e) Unsafe Condition

    This AD was prompted by a report of a trailing edge (TE) flap
rotary actuator that had slipped relative to its mating reaction
ring, which is attached to the flap support rib. We are issuing this
AD to detect and correct reaction ring gears and rotary actuator
gears from becoming disengaged with flaps extended and causing an
uncommanded roll due to flap blowback, overload, or flap departure
from the airplane, which could compromise safe flight and landing of
the airplane.

(f) Compliance

    Comply with this AD within the compliance times specified,
unless already done.

(g) Repetitive Inspections, Related Investigative Actions, and
Corrective Actions

    Except as provided by paragraph (h) of this AD, at the
applicable time specified in paragraph 1.E., ``Compliance,'' of
Boeing Alert Service Bulletin 767-27A0229, dated March 4, 2014: Do a
detailed inspection for corrosion of the rotary actuator assembly
fixed ring gear and reaction ring splines for each support position;
and do all applicable related investigative and corrective actions
if necessary; in accordance with the Accomplishment Instructions of
Boeing Alert Service Bulletin 767-27A0229, dated March 4, 2014. Do
all applicable related investigative and corrective actions before
further flight. Repeat the inspection of the rotary actuator
assembly fixed ring gear and reaction ring splines for each support
position thereafter at the applicable intervals specified in
paragraph 1.E., ``Compliance,'' of Boeing Alert Service Bulletin
767-27A0229, dated March 4, 2014.

(h) Exception to the Requirements of Paragraph (g) of This AD

    Where paragraph 1.E., ``Compliance,'' of Boeing Alert Service
Bulletin 767-27A0229, dated March 4, 2014, specifies a compliance
time ``after the original issue date of this service bulletin,''
this AD requires compliance within the specified compliance time
``after the effective date of this AD.''

(i) Alternative Methods of Compliance (AMOCs)

    (1) The Manager, Seattle Aircraft Certification Office (ACO),
FAA, has the authority to approve AMOCs for this AD, if requested
using the procedures found in 14 CFR 39.19. In accordance with 14
CFR 39.19, send your request to your principal inspector or local
Flight Standards District Office, as appropriate. If sending
information directly to the manager of the ACO, send it to the
attention of the person identified in paragraph (j) of this AD.
Information may be emailed to<EMAIL_ADDRESS>    (2) Before using any approved AMOC, notify your appropriate
principal inspector, or lacking a principal inspector, the manager
of the local flight standards district office/certificate holding
district office.
    (3) An AMOC that provides an acceptable level of safety may be
used for any repair required by this AD if it is approved by the
Boeing Commercial Airplanes Organization Designation Authorization
(ODA) that has been authorized by the Manager, Seattle ACO, to make
those findings. For a repair method to be approved, the repair must
meet the certification basis of the airplane and the approval must
specifically refer to this AD.
    (4) If the service information contains steps that are labeled
as RC (Required for Compliance), those steps must be done to comply
with this AD; any steps that are not labeled as RC are recommended.
Those steps that are not labeled as RC may be deviated from, done as
part of other actions, or done using accepted methods different from
those identified in the specified service information without
obtaining approval of an AMOC, provided the steps labeled as RC can
be done and the airplane can be put back in a serviceable condition.
Any substitutions or changes to steps labeled as RC require approval
of an AMOC.

(j) Related Information

    (1) For more information about this AD, contact Allen
Rauschendorfer, Aerospace Engineer, Airframe Branch, ANM-120S, FAA,
Seattle Aircraft Certification Office, 1601 Lind Avenue SW., Renton,
WA 98057-3356; phone:<PHONE_NUMBER>; fax:<PHONE_NUMBER>; email:
<EMAIL_ADDRESS>    (2) For service information identified in this AD, contact
Boeing Commercial Airplanes, Attention: Data & Services Management,
P.O. Box 3707, MC 2H-65, Seattle, WA 98124-2207; telephone 206-544-
5000, extension 1; fax<PHONE_NUMBER>; Internet https://www.myboeingfleet.com. You may view this referenced service
information at the FAA, Transport Airplane Directorate, 1601 Lind
Avenue SW., Renton, WA. For information on the availability of this
material at the FAA, call<PHONE_NUMBER>.

    Issued in Renton, Washington, on June 26, 2014.
Jeffrey E. Duven,
Manager, Transport Airplane Directorate, Aircraft Certification
Service.
[FR Doc. 2014-16004 Filed 7-8-14; 8:45 am]
BILLING CODE 4910-13-P


[Federal Register Volume 78, Number 128 (Wednesday, July 3, 2013)]
[Notices]
[Pages 40138-40140]
[FR Doc No: 2013-15865]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPP-2005-0057; FRL-9389-6]

Chlorpyrifos; Cancellation Order for Certain Pesticide
Registrations

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice announces EPA's order for the cancellations,
voluntarily requested by the registrant and accepted by the Agency, of
products containing chlorpyrifos, pursuant to the Federal Insecticide,
Fungicide, and Rodenticide Act (FIFRA). This cancellation order follows
a March 9, 2005 Federal Register Notice of Receipt of Request from the
registrant listed in Table 2 of Unit II. to voluntarily cancel these
product registrations. These are not the last products containing this
pesticide registered for use in the United States. In the March 9, 2005
notice, EPA indicated that it would issue an order implementing the
cancellations, unless the Agency received substantive comments within
the 180-day comment period that would merit its further review of these
requests, or unless the registrant withdrew their request. The Agency
did not receive any comments on the notice. Further, the registrant did
not withdraw their request. Accordingly, EPA hereby issues in this
notice a cancellation order granting the requested cancellations. Any
distribution, sale, or use of the products subject to this cancellation
order is permitted only in accordance with the terms of this order,
including any existing stocks provisions.

DATES: The cancellations are effective July 3, 2013.

FOR FURTHER INFORMATION CONTACT: Tom Myers, Pesticide Re-Evaluation
Division (7508P), Office of Pesticide Programs, Environmental
Protection Agency, 1200 Pennsylvania Ave. NW., Washington, DC 20460-
0001; telephone number:<PHONE_NUMBER>; fax number:<PHONE_NUMBER>;
email address<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this action apply to me?

    This action is directed to the public in general, and may be of
interest to a wide range of stakeholders including environmental, human
health, and agricultural advocates; the chemical industry; pesticide
users; and members of the public interested in the sale, distribution,
or use of pesticides. Since others also may be interested, the Agency
has not attempted to describe all the specific entities that may be
affected by this action.

B. How can I Get copies of this document and other related information?

    The docket for this action, identified by docket identification
(ID) number EPA-HQ-OPP-2005-0057, is available at http://www.regulations.gov or at the Office of Pesticide Programs Regulatory
Public Docket (OPP Docket) in the Environmental Protection Agency
Docket Center (EPA/DC), EPA West Bldg., Rm. 3334, 1301 Constitution
Ave. NW., Washington, DC 20460-0001. The Public Reading Room is open
from 8:30 a.m. to 4:30 p.m., Monday through Friday, excluding legal
holidays. The telephone number for the Public Reading Room is (202)
566-1744, and the telephone number for the OPP Docket is (703) 305-
5805. Please review the visitor instructions and additional information
about the docket available at http://www.epa.gov/dockets.

II. What action is the agency taking?

    This notice announces the cancellations, as requested by the
registrant, of the products registered under FIFRA section 3. These
registrations are listed in sequence by

registration number in Table 1 of this unit.

                                   Table 1--Chlorpyrifos Product Cancellations
----------------------------------------------------------------------------------------------------------------
      EPA Registration number                                       Product name
----------------------------------------------------------------------------------------------------------------
062719-00014......................  Dursban \1/2\ G Granular.
062719-00035......................  Dursban Turf Insecticide.
062719-00038......................  Lorsban 50-SI Wettable Powder.
062719-00039......................  Lorsban 50-W Wettable Powder.
062719-00054......................  Dursban 1-D.
062719-00068......................  Dursban 50w.
062719-00167......................  Equity.
062719-00255......................  Dursban 50W-N in Water Soluble Packets.
062719-00293......................  Dursban 75WG.
062719-00295......................  Lorsban 30G.
062719-00316......................  Dursban Plus Fertilizer 2.
062719-00349......................  Lentrek 6.
062719-00350......................  XRM-5222.
062719-00354......................  Dursban 30 SEC.
062719-00380......................  Lorsban 12.6%.
062719-00382......................  Chlorfos 4E Insecticide.
062719-00383......................  Chlorfos 15G.
CA940017..........................  Lorsban 4E-HF.
FL920007..........................  Lorsban 50W.
ID860017..........................  Dow Dursban 4E Insecticide.
LA960005..........................  Dursban TC Concentrate.
LA960007..........................  Equity Termiticide Concentrate.
MN960003..........................  Lorsban 4E-SG.
MS910008..........................  Equity Termiticide Concentrate.
MS930012..........................  Dursban 4E Insecticide.
MS960008..........................  Dursban TC Concentrate.
MS960009..........................  Equity Termiticide Concentrate.
MS960010..........................  Dursban TC Concentrate.
MS960014..........................  Dursban TC Concentrate.
ND950006..........................  Lorsban 4E-SG.
SC960003..........................  Dursban TC Concentrate.
SC960004..........................  Dursban TC Concentrate.
SC960005..........................  Equity Termiticide Concentrate.
TN900007..........................  Dursban Turf Insecticide
----------------------------------------------------------------------------------------------------------------

    Table 2 of this unit includes the name and address of record for
the registrant of the products listed in Table 1 of this unit, by EPA
company number. This number corresponds to the first part of the EPA
registration numbers of the products listed in Table 1 of this unit.

                Table 2--Registrant of Cancelled Products
------------------------------------------------------------------------
            EPA Company number                Company name and  address
------------------------------------------------------------------------
62719.....................................  Dow AgroSciences, LLC,
                                            9330 Zionsville Rd.,
                                            Indianapolis, IN 46268.
------------------------------------------------------------------------

III. Summary of Public Comments Received and Agency Response to
Comments

    During the public comment period provided, EPA received no comments
in response to the March 9, 2005 Federal Register notice announcing the
Agency's receipt of the request for voluntary cancellations of products
listed in Table 1 of Unit II.

 IV. Cancellation Order

    Pursuant to FIFRA section 6(f), EPA hereby approves the requested
cancellations of chlorpyrifos registrations identified in Table 1 of
Unit II. Accordingly, the Agency hereby orders that the product
registrations identified in Table 1 of Unit II. are canceled. The
effective date of the cancellations that are subject of this notice is
July 3, 2013. Any distribution, sale, or use of existing stocks of the
products identified in Table 1 of Unit II. in a manner inconsistent
with any of the provisions for disposition of existing stocks set forth
in Unit VI. will be a violation of FIFRA.

V. What is the agency's authority for taking this action?

    Section 6(f)(1) of FIFRA provides that a registrant of a pesticide
product may at any time request that any of its pesticide registrations
be canceled or amended to terminate one or more uses. FIFRA further
provides that, before acting on the request, EPA must publish a notice
of receipt of any such request in the Federal Register. Thereafter,
following the public comment period, the EPA Administrator may approve
such a request. The notice of receipt for this action was published for
comment on March 9, 2005 (70 FR 11634) (FRL-7701-3). The comment period
closed on September 6, 2005.

VI. Provisions for Disposition of Existing Stocks

    Existing stocks are those stocks of registered pesticide products
which are currently in the United States and which were packaged,
labeled, and released for shipment prior to the effective date of the
cancellation action. The Federal Register Notice of March 9, 2005,
proposed to allow without limitation the distribution or sale of
existing stocks by non-registrants, as well as the use of existing
stocks. However, over 8 years have now passed since that notice was
published and it is EPA's understanding that the registrant has not
produced the products since that time. As a result, EPA believes there
is likely little if any product remaining in the channels of

trade and believes what little there may be of these old products
should no longer be put to use. Accordingly, the cancellation order
issued in this notice includes the following existing stocks
provisions: The cancellation order issued in this notice includes the
following existing stocks provisions.
    The distribution, sale or use of existing stocks will not be lawful
under FIFRA with the date of this cancellation order except for the
purpose of returns and relabeling, shipping such stocks for export
consistent with the requirements of section 17 of FIFRA, or for proper
disposal.

List of Subjects

    Environmental protection, Pesticides and pests.

    Dated: June 10, 2013.
Richard P. Keigwin, Jr.,
Director, Pesticide Re-Evaluation Division, Office of Pesticide
Programs.
[FR Doc. 2013-15865 Filed 7-2-13; 8:45 am]
BILLING CODE 6560-50-P


[Federal Register Volume 79, Number 193 (Monday, October 6, 2014)]
[Notices]
[Pages 60223-60225]
[FR Doc No: 2014-23704]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-73267; File No. SR-NYSEArca-2014-108]

Self-Regulatory Organizations; NYSE Arca, Inc.; Notice of Filing
and Immediate Effectiveness of Proposed Rule Change Amending Exchange
Rule 6.1A To Codify the Terms Complex BBO and Complex NBBO and To Amend
Rule 6.62(y) To Revise the Definition of a PNP Plus Order

September 30, 2014.
    Pursuant to Section 19(b)(1) \1\ of the Securities Exchange Act of
1934 (the ``Act'') \2\ and Rule 19b-4 thereunder,\3\ notice is hereby
given that, on September 17, 2014, NYSE Arca, Inc. (the ``Exchange'' or
``NYSE Arca'') filed with the Securities and Exchange Commission (the
``Commission'') the proposed rule change as described in Items I and II
below, which Items have been prepared by the self-regulatory
organization. The Commission is publishing this notice to solicit
comments on the proposed rule change from interested persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C.78s(b)(1).
    \2\ 15 U.S.C. 78a.
    \3\ 17 CFR 240.19b-4.
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    The Exchange proposes to amend Exchange Rule 6.1A to codify the
terms Complex BBO and Complex NBBO and to amend Rule 6.62(y) to revise
the definition of a PNP Plus order. The text of the proposed rule
change is available on the Exchange's Web site at www.nyse.com, at the
principal office of the Exchange, and at the Commission's Public
Reference Room.

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, the self-regulatory organization
included statements concerning the purpose of, and basis for, the
proposed rule change and discussed any comments it received on the
proposed rule change. The text of those statements may be examined at
the places specified in Item IV below. The Exchange has prepared
summaries, set forth in sections A, B, and C below, of the most
significant parts of such statements.

A. Self-Regulatory Organization's Statement of the Purpose of, and the
Statutory Basis for, the Proposed Rule Change

1. Purpose
    The Exchange proposes to amend Rule 6.1A to adopt definitions for
the terms Complex BBO and Complex NBBO. Additionally, the Exchange
proposes to amend Rule 6.62(y) by revising the definition of PNP Plus
orders, to specify that the order type is available solely for
Electronic Complex Orders,\4\ and to describe the processing of an
Electronic Complex Order designated as PNP Plus.
---------------------------------------------------------------------------

    \4\ See Rule 6.91.
---------------------------------------------------------------------------

Complex BBO and Complex NBBO
    The term BBO is defined in Exchange Rule 6.1A(a)(2) as the best bid
or offer on OX,\5\ and the term NBBO is defined in Exchange Rule
6.1A(a)(11) as the national best bid or offer. In both cases the best
bid and offer represents the best price available in an individual
option series as disseminated by either the Exchange (in the case of
the BBO) or the Options Price Reporting Authority (``OPRA'') (in the
case of the NBBO). Unlike bids and offers for each individual option
series, derived bids and offers for Complex Orders are not disseminated
by either the Exchange or OPRA.
---------------------------------------------------------------------------

    \5\ OX is the Exchange's electronic order delivery, execution
and reporting system for options through which orders and quotes are
consolidated for execution and/or display. See Rule 6.1A(a)(13).
---------------------------------------------------------------------------

    Even though there is not a published bid or offer for every complex
order strategy, there are situations where it is necessary to derive a
(theoretical) bid or offer for a particular strategy.\6\ In order to
derive the best bid or best offer for a given complex order strategy
the Exchange takes the best bid and best offer in the individual leg
markets comprising the complex order strategy, that when aggregated
create either a derived Complex BBO or derived Complex NBBO for that
same strategy. The Exchange uses the best quotes available on the
Exchange in each component series (as shown in OX) to create the
Complex BBO and the best quotes available nationally in each component
series (as disseminated by

OPRA) to establish the Complex NBBO. When deriving the Complex BBO or
Complex NBBO the Exchange only factors in the best prices available in
the individual leg markets and does not take into consideration prices
of individual Complex Orders that may be resting on the Exchange or in
another exchange's complex order book (spread book, contingency book).
---------------------------------------------------------------------------

    \6\ For example, the Complex Matching Engine utilizes a Complex
NBBO when establishing the acceptable price range applicable to the
opening auction process for Electronic Complex Orders. See Rule
6.91(a)(2)(i)(B).
---------------------------------------------------------------------------

    The Exchange proposes to add definitions of the terms Complex BBO
and Complex NBBO in Rule 6.1A. The term ``Complex BBO'' would be
defined in Rule 6.1A(a)(2)(ii) as the BBO for a given complex order
strategy as derived from the best bid on OX and best offer on OX for
each individual component series of a Complex Order. The term ``Complex
NBBO'' would be defined in Rule 6.1A(a)(11)(ii) as the NBBO for a given
complex order strategy as derived from the national best bid and
national best offer for each individual component series of a Complex
Order.
    An example of how the Complex BBO and Complex NBBO is derived for a
given strategy is shown below;

Jan 20 calls BBO 2.00 x 2.20 NBBO 2.05-2.20
Jan 25 calls BBO 1.00 x 1.20 NBBO 1.05-1.20

    To derive the bid side of the Complex BBO for the Jan 20/25 call
spread using the markets available on the Exchange, the Exchange takes
the best bid in the Jan 20 calls coupled with the best offer in the Jan
25 calls. The result is an .80 bid (2.00-1.20 = .80). To derive the
offer side of the Complex BBO for the same call spread the Exchange
take the best offer in the Jan 20 calls coupled with the best bid in
the Jan 25 calls. The result is an offer of 1.20 (2.20-1.00 = 1.20). In
this example, the resulting Complex BBO is .80-1.20.
    To derive the bid side of the Complex NBBO for the Jan 20/25 call
spread using the markets as disseminated by OPRA, the Exchange takes
the national best bid in the Jan 20 calls coupled with the national
best offer in the Jan 25 calls. This results in an .85 bid (2.05-1.20 =
.85). To derive the offer side of the Complex NBBO for the same call
spread the Exchange take the national best offer in the Jan 20 calls
coupled with the national best bid in the Jan 25 calls. This results in
an offer of 1.15 (2.20-1.05=1.15). In this example, the resulting
Complex NBBO is .85-1.15.
PNP Plus
    As defined in Rule 6.62(y), an order designated as PNP Plus is a
limit order that is automatically re-priced by the Exchange to a price
that is one minimum price variation (``MPV'') higher (lower) than the
NBBO bid (offer) if it were to lock or cross the NBBO. The re-priced
order is then posted in the Consolidated Book. PNP Plus orders continue
to be re-priced and re-posted in the Consolidated Book with each change
in the NBBO until such time as the NBBO has moved to a price where the
original limit price of the PNP Plus order no longer locks or crosses
the NBBO, at which time the PNP Plus order will revert to the original
limit price of such order. Orders designated as PNP Plus are ranked in
the Consolidated Book pursuant to Rule 6.76 and assigned a new price
time priority as of the time of each reposting. Because an order
designated as PNP Plus would be posted at a price that is higher
(lower) that [sic] the best contra-side market, by designating an order
as PNP Plus, a market participant could guarantee that if its order
were to be executed, it would be executed at a price that is better
than the disseminated contra-side market. Accordingly, PNP Plus
provides OTP Holders with additional processing capability to control
the circumstances under which their orders are executed. The Exchange
notes that the PNP Plus order type is currently not operable for
single-leg orders, nor does the Exchange intend to introduce such
functionality in the near future. OTP Holders are able to and do use
the PNP Plus designation when submitting Electronic Complex Orders.
Accordingly, the Exchange is proposing to amend the definition of the
PNP Plus order type to make it applicable solely to Electronic Complex
Orders.
    In addition, the revised rule would explain that the net debit/
credit price \7\ of an Electronic Complex Order designated as PNP Plus
is re-priced based on the Complex BBO for the same complex order
strategy. An Electronic Complex Order designated as PNP Plus would
follow existing PNP Plus processing in that the order will be
automatically re-priced by the Exchange to a price that is one MPV
lower (higher) than the displayed contra-side market for buy orders
(sell orders) if it were to lock or cross that market. However, because
the leg prices of an Electronic Complex Order are bound by the best bid
or offer on the Exchange and not the national best bid or offer \8\ as
is the case with single-leg orders, when re-pricing an Electronic
Complex Order designated as PNP Plus, the order would be re-priced one
MPV lower (higher) than the Complex BBO if it were to lock or cross the
Complex BBO.
---------------------------------------------------------------------------

    \7\ Bids and offers for Electronic Complex Orders are entered
based on the net debit/credit of prices of the individual component
series comprising the complex order strategy.
    \8\ See Rule 6.91(a)(2).
---------------------------------------------------------------------------

    Accordingly, as amended, Rule 6.62(y) would state that an
Electronic Complex Order designated as PNP Plus is automatically re-
priced by the Exchange to an MPV higher (for sell orders) than the
Complex BBO bid for that same Complex Order strategy or at an MPV lower
(for buy orders) than the Complex BBO offer for that same Complex Order
strategy for any unexecuted portion of the Electronic Complex Order
designated as PNP Plus that would otherwise lock or cross the Complex
BBO. The Exchange notes that because bids and offers for Electronic
Complex Orders are priced on a net debit/credit basis and may be
expressed in any decimal price, and the legs(s) of an Electronic
Complex Order may be executed in one cent increments regardless of the
MPV otherwise applicable to the individual legs of the order,\9\ the
MPV applicable to an Electronic Complex Order designated as PNP Plus
will always be $0.01 cent. The re-priced order would then be posted in
the Consolidated Book pursuant to Rule 6.91(a)(1).
---------------------------------------------------------------------------

    \9\ See Rule 6.91 Commentary .01.
---------------------------------------------------------------------------

    Finally, the Exchange proposes to change the existing cross
reference in Rule 6.62(y) from Rule 6.76 to 6.91(a)(1). This is a non-
substantive change as both rules call for orders to be ranked according
to price/time priority. The Exchange believes Rule 6.91(a)(1) is the
more appropriate rule to reference because it is specific to Electronic
Complex Orders. For the purposes of ranking in the Consolidated Book,
Electronic Complex Orders designated as PNP Plus shall initially be
ranked based on their original time of entry and assigned a new price/
time priority as of the time of each re-posting. From there, with the
exception of the use of the Complex BBO rather than the NBBO, all other
PNP Plus functionality remains unchanged.
2. Statutory Basis
    The Exchange believes that its proposal is consistent with Section
6(b)(5) of the Securities Exchange Act of 1934 (the ``Act''),\10\ which
requires the rules of an exchange to promote just and equitable
principles of trade, to remove impediments to and perfect the mechanism
of a free and open market and a national market system and, in general,
to protect investors and the public interest. The Exchange believes
that the proposed rule change would

remove impediments to and perfect the mechanism of a free and open
market and a national market system because it would provide
transparency in Exchange rules that the PNP Plus is a designation
applicable to Electronic Complex Orders. The Exchange further believes
that revising the PNP Plus definition to describe how an Electronic
Complex Order designated as PNP Plus is re-price [sic] based off the
Complex BBO and not the NBBO would align the rule with existing
functionality and rules governing Electronic Complex Orders.
---------------------------------------------------------------------------

    \10\ 15 U.S.C. 78f(b).
---------------------------------------------------------------------------

    The Exchange also believes that [sic] proposed rule change would
perfect the mechanism of a free and open market because by revising the
PNP Plus order type to make the designation available solely for
Electronic Complex Orders, and not for single leg orders, the rule
would clearly describe the applicability of the PNP Plus order type and
eliminate any suggestion of an order type for which there is no
demonstrated demand and is not supported by Exchange systems.
    The Exchange also believes that defining the terms Complex BBO and
Complex NBBO will help to remove impediments to and perfect the
mechanism of a free and open market and a national market system, in
general because it would provide all market participants with
additional clarity in how the Exchange calculates the Complex BBO and
Complex NBBO in connection with the processing of Complex Orders.
    In addition, the Exchange believes that the proposal would remove
impediments to and perfect the mechanism of a free and open market by
ensuring that members, regulators and the public can more easily
navigate the Exchange's rulebook and better understand the orders types
available for trading on the Exchange.

B. Self-Regulatory Organization's Statement on Burden on Competition

    The Exchange does not believe that the proposed rule change would
impose any burden on competition that is not necessary or appropriate
in furtherance of the purposes of the Act. The proposed change is not
designed to address any competitive issue but rather revise an existing
a [sic] rule, that can be seen as inaccurate or incomplete, by
accurately describing functionality applicable to the PNP Plus order
type and describing the processing of an Electronic Complex Order
designated as PNP Plus, thereby reducing confusion and making the
Exchange's rules easier to understand and navigate. Also, adopting
Complex BBO and Complex NBBO as defined terms is intended to add
clarity into Exchange rules regarding the methodology of how a Complex
BBO and a Complex NBBO is derived and therefore does not raise any
competitive concerns.

C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants, or Others

    No written comments were solicited or received with respect to the
proposed rule change.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    The Exchange has filed the proposed rule change pursuant to Section
19(b)(3)(A)(iii) of the Act \11\ and Rule 19b-4(f)(6) thereunder.\12\
Because the proposed rule change does not: (i) Significantly affect the
protection of investors or the public interest; (ii) impose any
significant burden on competition; and (iii) become operative prior to
30 days from the date on which it was filed, or such shorter time as
the Commission may designate, if consistent with the protection of
investors and the public interest, the proposed rule change has become
effective pursuant to Section 19(b)(3)(A) of the Act and Rule 19b-
4(f)(6) thereunder.\13\
---------------------------------------------------------------------------

    \11\ 15 U.S.C. 78s(b)(3)(A)(iii).
    \12\ 17 CFR 240.19b-4(f)(6).
    \13\ 17 CFR 240.19b-4(f)(6). As required under Rule 19b-
4(f)(6)(iii), the Exchange provided the Commission with written
notice of its intent to file the proposed rule change, along with a
brief description and the text of the proposed rule change, at least
five business days prior to the date of filing of the proposed rule
change, or such shorter time as designated by the Commission.
---------------------------------------------------------------------------

    At any time within 60 days of the filing of such proposed rule
change, the Commission summarily may temporarily suspend such rule
change if it appears to the Commission that such action is necessary or
appropriate in the public interest, for the protection of investors, or
otherwise in furtherance of the purposes of the Act. If the Commission
takes such action, the Commission shall institute proceedings under
Section 19(b)(2)(B) \14\ of the Act to determine whether the proposed
rule change should be approved or disapproved.
---------------------------------------------------------------------------

    \14\ 15 U.S.C. 78s(b)(2)(B).
---------------------------------------------------------------------------

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views, and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:

Electronic Comments

     Use the Commission's Internet comment form (http://www.sec.gov/rules/sro.shtml); or
     Send an email to<EMAIL_ADDRESS>Please include
File Number SR-NYSEArca-2014-108 on the subject line.

Paper Comments

     Send paper comments in triplicate to Secretary, Securities
and Exchange Commission, 100 F Street NE., Washington, DC 20549-1090.

All submissions should refer to File Number SR-NYSEArca-2014-108. This
file number should be included on the subject line if email is used. To
help the Commission process and review your comments more efficiently,
please use only one method. The Commission will post all comments on
the Commission's Internet Web site (http://www.sec.gov/rules/sro.shtml). Copies of the submission, all subsequent amendments, all
written statements with respect to the proposed rule change that are
filed with the Commission, and all written communications relating to
the proposed rule change between the Commission and any person, other
than those that may be withheld from the public in accordance with the
provisions of 5 U.S.C. 552, will be available for Web site viewing and
printing in the Commission's Public Reference Room, 100 F Street, NE.,
Washington, DC 20549, on official business days between the hours of
10:00 a.m. and 3:00 p.m. Copies of the filing also will be available
for inspection and copying at the NYSE's principal office and on its
Internet Web site at www.nyse.com. All comments received will be posted
without change; the Commission does not edit personal identifying
information from submissions. You should submit only information that
you wish to make available publicly. All submissions should refer to
File Number SR-NYSEArca-2014-108 and should be submitted on or before
October 27, 2014.

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\15\
Kevin M. O'Neill,
Deputy Secretary.
---------------------------------------------------------------------------

    \15\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

[FR Doc. 2014-23704 Filed 10-3-14; 8:45 am]
BILLING CODE 8011-01-P